Vanessa Rivera-Amill to United States
This is a "connection" page, showing publications Vanessa Rivera-Amill has written about United States.
Connection Strength
0.051
-
Guerrero-Preston R, Rivera-Amill V, Caraballo K, Rodr?guez-Torres S, Purcell-Wiltz A, Garc?a AA, Torres RS, Zamuner FT, Zanettini C, MacKay MJ, Baits R, Salgado D, Khullar G, Metti J, Baker T, Dudley J, Vale K, P?rez G, De Jes?s L, Miranda Y, Ortiz D, Garc?a-Negr?n A, Viera L, Ortiz A, Canabal JA, Romaguera J, Jim?nez-Vel?zquez I, Marchionni L, Rodr?guez-Orengo JF, Baez A, Mason CE, Sidransky D. Precision health diagnostic and surveillance network uses S gene target failure (SGTF) combined with sequencing technologies to track emerging SARS-CoV-2 variants. Immun Inflamm Dis. 2022 06; 10(6):e634.
Score: 0.026
-
Munoz-Jordan J, Cardona J, Beltr?n M, Col?n C, Schiffer J, Stewart-Clark E, Zellner B, Semenova V, Li Y, Jia LT, Maniatis P, Pawloski L, Adams L, Paz-Bailey G, Rivera-Amill V, Medina F. Evaluation of Serologic Cross-Reactivity Between Dengue Virus and SARS-CoV-2 in Patients with Acute Febrile Illness - United States and Puerto Rico, April 2020-March 2021. MMWR Morb Mortal Wkly Rep. 2022 Mar 11; 71(10):375-377.
Score: 0.025